3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
11
Thoracic
8
Gastrointestinal
7
Lymphoid
5
Tumor-Agnostic
4
Other hematologic neoplasm
4
Plasma cell
3
Genitourinary
3
Other
1
Dermatologic
1
CNS
1
Conditions
Skin Neoplasms
1
Melanoma
1
Interventions
pembrolizumab
69
Nivolumab
57
Ipilimumab
36
Specimen Handling
32
Magnetic Resonance Spectroscopy
25
Cyclophosphamide
23
Biopsy
18
cemiplimab
14
fludarabine
13
relatlimab
11
binimetinib
11
Opdualag
11
CTLA-4 Antigen
11
trametinib
10
fludarabine phosphate
10
Radiosurgery
10
avelumab
9
Radiotherapy
9
lifileucel
8
dabrafenib
8
Blood Specimen Collection
8
atezolizumab
7
aldesleukin
7
Paclitaxel
7
encorafenib
6
X-Rays
6
Standard of Care
6
Interleukin-2
6
Immunoglobulin G
6
HhAntag691
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Exercise
×
Dermatologic
×
90 days
×
Clear all
NCT06694571
2026-04-03
STARS
University of Utah
Phase NA
Completed
38 enrolled
9 charts